C752 CAR-T Cells therapy(Shanghai PerHum Therapeutics)

N/A

Report date: 2025/02/19 20:00:46

Base Information

Drug NameC752 CAR-T Cells therapy(Shanghai PerHum Therapeutics)

Drug Alias NameC752

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsLymphoma, B-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaDiscontinued

Originator CompaniesShanghai Sinobioway Sunterra Biotech

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesShanghai Sinobioway Sunterra Biotech

Active IndicationsN/A

Inactive IndicationsLymphoma, B-Cell

Other Information

ATC CodeN/A